205 related articles for article (PubMed ID: 38374239)
1. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice.
Wang Y; Gu YH; Ren KW; Xie X; Wang SH; Zhu XX; Wang L; Yang XL; Bi HL
Hypertens Res; 2024 May; 47(5):1309-1322. PubMed ID: 38374239
[TBL] [Abstract][Full Text] [Related]
2. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH
Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551
[TBL] [Abstract][Full Text] [Related]
3. Administration of USP7 inhibitor P22077 inhibited cardiac hypertrophy and remodeling in Ang II-induced hypertensive mice.
Gu YH; Ren KW; Wang Y; Wang SH; Yu XH; Xu LW; Li HH; Bi HL
Front Pharmacol; 2022; 13():1021361. PubMed ID: 36386139
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin I
Zhang Y; Yuan M; Cai W; Sun W; Shi X; Liu D; Song W; Yan Y; Chen T; Bao Q; Zhang B; Liu T; Zhu Y; Zhang X; Li G
Cell Mol Life Sci; 2024 Jun; 81(1):264. PubMed ID: 38878214
[TBL] [Abstract][Full Text] [Related]
5. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways.
Jiang XX; Zhang R; Wang HS
Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722
[TBL] [Abstract][Full Text] [Related]
6. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
[TBL] [Abstract][Full Text] [Related]
7. Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice.
Li J; Wang S; Bai J; Yang XL; Zhang YL; Che YL; Li HH; Yang YZ
Hypertension; 2018 May; 71(5):866-876. PubMed ID: 29507100
[TBL] [Abstract][Full Text] [Related]
8. Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice.
Ren KW; Yu XH; Gu YH; Xie X; Wang Y; Wang SH; Li HH; Bi HL
Front Cardiovasc Med; 2022; 9():957903. PubMed ID: 36304536
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of UCHL1 by LDN-57444 attenuates Ang II-Induced atrial fibrillation in mice.
Bi HL; Zhang YL; Yang J; Shu Q; Yang XL; Yan X; Chen C; Li Z; Li HH
Hypertens Res; 2020 Mar; 43(3):168-177. PubMed ID: 31700166
[TBL] [Abstract][Full Text] [Related]
10. H
Lu G; Xu C; Tang K; Zhang J; Li Q; Peng L; Wang Y; Huang Z; Gao X
Biochem Biophys Res Commun; 2017 Jan; 483(1):534-540. PubMed ID: 28011270
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
12. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
[TBL] [Abstract][Full Text] [Related]
13. Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling.
Zhan G; Wang X; Wang X; Li J; Tang Y; Bi H; Yang X; Xia Y
Eur J Pharmacol; 2024 Jun; 978():176712. PubMed ID: 38906237
[TBL] [Abstract][Full Text] [Related]
14. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway.
Wu Y; Can J; Hao S; Qiang X; Ning Z
Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
[TBL] [Abstract][Full Text] [Related]
16. Adipose Triglyceride Lipase Deficiency Aggravates Angiotensin II-Induced Atrial Fibrillation by Reducing Peroxisome Proliferator-Activated Receptor α Activation in Mice.
Han X; Zhang YL; Zhao YX; Guo SB; Yin WP; Li HH
Lab Invest; 2023 Jan; 103(1):100004. PubMed ID: 36748188
[TBL] [Abstract][Full Text] [Related]
17. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W
J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577
[TBL] [Abstract][Full Text] [Related]
18. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
[TBL] [Abstract][Full Text] [Related]
19. Novel preventive effect of isorhamnetin on electrical and structural remodeling in atrial fibrillation.
Aonuma K; Xu D; Murakoshi N; Tajiri K; Okabe Y; Yuan Z; Li S; Murakata Y; Tominaga K; Nogami A; Aonuma K; Ieda M; Isoda H
Clin Sci (Lond); 2022 Dec; 136(24):1831-1849. PubMed ID: 36540030
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-33/ST2 axis involvement in atrial remodeling and arrhythmogenesis.
Cheng TY; Chen YC; Li SJ; Lin FJ; Lu YY; Lee TI; Lee TW; Higa S; Kao YH; Chen YJ
Transl Res; 2024 Jun; 268():1-12. PubMed ID: 38244770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
